Understanding the heterogeneous immune repertoire of brain metastases for designing next‐gen therapeutics
Abstract Approximately 20% of cancer patients experience brain metastases in the advanced stages as circulating tumor cells migrate to and colonize the brain microvasculature. Due to the challenges associated with biopsies, our understanding of the tumor microenvironment and heterogeneity in brain m...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-09-01
|
| Series: | Brain-X |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brx2.33 |